Eight Roads

Cataya Bio (Shanghai) Co., Ltd. is focused on developing synthetic biological products for diverse industries through its advanced engineering biology platform and biomanufacturing capabilities. The company engineers microbes and creates clean fermentation processes to produce high-purity products sustainably and cost-effectively. By leveraging synthetic biology technology, Cataya Bio enables clients to obtain natural and sustainable raw materials, contributing to a shift away from petroleum-based resources. The company's efforts address critical global challenges such as environmental preservation, carbon emissions, and climate change.

Redpine is a manufacturer of disposable medical endoscopes, specializing in single-use devices designed for minimally invasive surgical procedures. Founded in 2015 and headquartered in Guangzhou, China, the company aims to be a leading provider of integrated solutions across various medical fields, including urology, gynecology, ENT, pneumology, gastroenterology, and general surgeries. Redpine focuses on delivering advanced medical solutions that enhance detection, diagnosis, and treatment processes, supporting healthcare professionals with innovative tools to improve patient outcomes.

Ruiyun Cold Chain is a logistics service platform in China that utilizes innovative domestic technology to offer comprehensive cold chain transportation solutions. The company provides digital, end-to-end integration services designed to optimize operational efficiency for its customers. Through its unique platform, which includes Lengyunbao—an online trading platform for carriers—and a dual-end app, Ruiyun Cold Chain facilitates smooth transactions, deliveries, settlements, and tax collection. By fostering collaboration within the cold chain network, the company effectively reduces logistics costs for cargo owners by 10% to 15%, linking industry resources with customer demand through digital intelligence.

Cataya Bio (Shanghai) Co., Ltd. is focused on developing synthetic biological products for diverse industries through its advanced engineering biology platform and biomanufacturing capabilities. The company engineers microbes and creates clean fermentation processes to produce high-purity products sustainably and cost-effectively. By leveraging synthetic biology technology, Cataya Bio enables clients to obtain natural and sustainable raw materials, contributing to a shift away from petroleum-based resources. The company's efforts address critical global challenges such as environmental preservation, carbon emissions, and climate change.

Qixiangyun is an innovative company in China that specializes in financial and taxation technology services. It operates the first open platform aimed at empowering Independent Software Vendors (ISVs) and terminal enterprises by providing high-quality standard components for financial and taxation systems. The platform features an intelligent financial and tax report accounting engine at its core, along with APIs and configurable functional modules that can be seamlessly integrated into various enterprise software systems. This integration allows clients to enhance their digital transformation efforts and streamline processes such as multi-enterprise and cross-regional tax declaration and deduction. By facilitating these advancements, Qixiangyun helps enterprises effectively navigate the complexities of business finance and taxation, contributing to their overall digital transformation.

Jade Bird Display (Shanghai) Limited is a manufacturer specializing in the development and production of micro-LED display chips and panels, primarily designed for augmented reality (AR) and virtual reality (VR) applications. Founded in 2015 and headquartered in Shanghai, with an additional office in Hong Kong, the company focuses on creating the smallest, brightest, and most efficient micro-display technology. Its products are utilized in a variety of applications including head-up displays, projectors, weapon sights, 3D printing, and microscopes. By providing ultra-compact micro-display panels and light engines, Jade Bird Display enables original equipment manufacturers to enhance user comfort and outdoor readability, while also extending operating times between charges for next-generation AR and VR hardware.

Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.

UWinTech is a comprehensive provider of IT operations and maintenance solutions, established in 2015 and headquartered in Shenzhen, China. The company specializes in application management services that encompass continuous delivery, continuous deployment, operation automation, and application monitoring. Its product offerings include EasyCMDB, Easydevops, Easyobserve, EasyMAbuilder, and Easyautoops. By delivering these integrated services, UWinTech aims to assist enterprises in streamlining their IT operations, thereby reducing operational efforts and enhancing productivity.

Ruiyun Cold Chain is a logistics service platform in China that utilizes innovative domestic technology to offer comprehensive cold chain transportation solutions. The company provides digital, end-to-end integration services designed to optimize operational efficiency for its customers. Through its unique platform, which includes Lengyunbao—an online trading platform for carriers—and a dual-end app, Ruiyun Cold Chain facilitates smooth transactions, deliveries, settlements, and tax collection. By fostering collaboration within the cold chain network, the company effectively reduces logistics costs for cargo owners by 10% to 15%, linking industry resources with customer demand through digital intelligence.

Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.

Blueglass Yogurt is a food and beverage brand based in China that specializes in producing and selling a diverse range of yogurt-based products. The company's offerings include various categories such as signature fancy yogurt, fruit yogurt, yogurt salads, cakes, and ice cream. By operating its own stores, Blueglass Yogurt ensures that customers enjoy freshly made yogurt, enhancing the overall consumer experience. The brand aims to cater to the tastes of domestic consumers by providing high-quality yogurt products in a variety of formats, including beverages and desserts.

Ruiyun Cold Chain is a logistics service platform in China that utilizes innovative domestic technology to offer comprehensive cold chain transportation solutions. The company provides digital, end-to-end integration services designed to optimize operational efficiency for its customers. Through its unique platform, which includes Lengyunbao—an online trading platform for carriers—and a dual-end app, Ruiyun Cold Chain facilitates smooth transactions, deliveries, settlements, and tax collection. By fostering collaboration within the cold chain network, the company effectively reduces logistics costs for cargo owners by 10% to 15%, linking industry resources with customer demand through digital intelligence.

Know Yourself is a prominent psychology education platform based in China, dedicated to enhancing mental health and well-being among urban youth. With a substantial following of over 3 million on social media, the platform offers a variety of psychoeducational resources, including articles, lectures, and courses. It serves as the largest online community for psychological education in the country, promoting mental health awareness through self-help tools, a supportive community, and a range of psychology-related services. These services cover areas such as self-exploration, developmental psychology, and clinical psychology, aiming to provide valuable insights and support for individuals seeking to understand and improve their mental health.

B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.

Pony.ai, Inc. is a technology company specializing in autonomous driving solutions and artificial intelligence software for automated vehicle manufacturing. Founded in 2016 and headquartered in Fremont, California, with additional offices in San Francisco and China, Pony.ai develops systems that utilize machine learning to navigate vehicles across diverse driving conditions. The company's technology focuses on accurately perceiving the vehicle's environment and predicting driver actions to enhance safety and functionality. In addition to its core development efforts, Pony.ai also operates a public-facing Robotaxi service, showcasing its advancements in autonomous mobility. Through collaborations with automotive manufacturers, Pony.ai aims to integrate its innovative technology into commercial vehicles, significantly contributing to the evolution of transportation.

Redpine is a manufacturer of disposable medical endoscopes, specializing in single-use devices designed for minimally invasive surgical procedures. Founded in 2015 and headquartered in Guangzhou, China, the company aims to be a leading provider of integrated solutions across various medical fields, including urology, gynecology, ENT, pneumology, gastroenterology, and general surgeries. Redpine focuses on delivering advanced medical solutions that enhance detection, diagnosis, and treatment processes, supporting healthcare professionals with innovative tools to improve patient outcomes.

Pony.ai, Inc. is a technology company specializing in autonomous driving solutions and artificial intelligence software for automated vehicle manufacturing. Founded in 2016 and headquartered in Fremont, California, with additional offices in San Francisco and China, Pony.ai develops systems that utilize machine learning to navigate vehicles across diverse driving conditions. The company's technology focuses on accurately perceiving the vehicle's environment and predicting driver actions to enhance safety and functionality. In addition to its core development efforts, Pony.ai also operates a public-facing Robotaxi service, showcasing its advancements in autonomous mobility. Through collaborations with automotive manufacturers, Pony.ai aims to integrate its innovative technology into commercial vehicles, significantly contributing to the evolution of transportation.

B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.

Medbanks Network Technology, founded in 2014 and based in Beijing, specializes in data processing services for the healthcare sector. The company focuses on developing an oncology database that compiles clinical and professional medical service information gathered from hospitals. This resource aims to enhance the understanding and management of cancer care. In addition, Sipai Health Technology Co Ltd operates within the medical technology and health management space in China, encompassing three main segments: specialty pharmacy, physician research assistance, and health insurance services. The specialty pharmacy segment is the primary revenue driver, while the company predominantly conducts its business within the People's Republic of China.

Hedone is an e-commerce platform based in Shanghai, China, specializing in beauty and makeup products. Founded in 2014, the company primarily targets Chinese millennials, offering a range of fashion and beauty items that cater to their individual identities and preferences. By focusing on this demographic, Hedone aims to resonate with younger consumers seeking products that reflect their personal style.

Medbanks Network Technology, founded in 2014 and based in Beijing, specializes in data processing services for the healthcare sector. The company focuses on developing an oncology database that compiles clinical and professional medical service information gathered from hospitals. This resource aims to enhance the understanding and management of cancer care. In addition, Sipai Health Technology Co Ltd operates within the medical technology and health management space in China, encompassing three main segments: specialty pharmacy, physician research assistance, and health insurance services. The specialty pharmacy segment is the primary revenue driver, while the company predominantly conducts its business within the People's Republic of China.

B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.

Pony.ai, Inc. is a technology company specializing in autonomous driving solutions and artificial intelligence software for automated vehicle manufacturing. Founded in 2016 and headquartered in Fremont, California, with additional offices in San Francisco and China, Pony.ai develops systems that utilize machine learning to navigate vehicles across diverse driving conditions. The company's technology focuses on accurately perceiving the vehicle's environment and predicting driver actions to enhance safety and functionality. In addition to its core development efforts, Pony.ai also operates a public-facing Robotaxi service, showcasing its advancements in autonomous mobility. Through collaborations with automotive manufacturers, Pony.ai aims to integrate its innovative technology into commercial vehicles, significantly contributing to the evolution of transportation.

UWinTech is a comprehensive provider of IT operations and maintenance solutions, established in 2015 and headquartered in Shenzhen, China. The company specializes in application management services that encompass continuous delivery, continuous deployment, operation automation, and application monitoring. Its product offerings include EasyCMDB, Easydevops, Easyobserve, EasyMAbuilder, and Easyautoops. By delivering these integrated services, UWinTech aims to assist enterprises in streamlining their IT operations, thereby reducing operational efforts and enhancing productivity.

Hua Medicine, established in 2009, is a Shanghai-based clinical-stage drug development company. It specializes in therapies for diabetes and central nervous system (CNS) disorders in China. The company's primary focus is Dorzagliatin, an oral drug for Type 2 diabetes, which is in Phase 3 clinical trials, both as a standalone treatment and in combination with metformin. Additionally, Hua Medicine is developing Dorzagliatin in combination with other drugs and mGLUR5 for Parkinson's disease levodopa-induced dyskinesia, both in pre-clinical stages. The company's mission is to address unmet medical needs in China through innovative drug development.

B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.

UWinTech is a comprehensive provider of IT operations and maintenance solutions, established in 2015 and headquartered in Shenzhen, China. The company specializes in application management services that encompass continuous delivery, continuous deployment, operation automation, and application monitoring. Its product offerings include EasyCMDB, Easydevops, Easyobserve, EasyMAbuilder, and Easyautoops. By delivering these integrated services, UWinTech aims to assist enterprises in streamlining their IT operations, thereby reducing operational efforts and enhancing productivity.

Hua Medicine, established in 2009, is a Shanghai-based clinical-stage drug development company. It specializes in therapies for diabetes and central nervous system (CNS) disorders in China. The company's primary focus is Dorzagliatin, an oral drug for Type 2 diabetes, which is in Phase 3 clinical trials, both as a standalone treatment and in combination with metformin. Additionally, Hua Medicine is developing Dorzagliatin in combination with other drugs and mGLUR5 for Parkinson's disease levodopa-induced dyskinesia, both in pre-clinical stages. The company's mission is to address unmet medical needs in China through innovative drug development.

Founded in November 2013, QuanCheng is a Shanghai-based startup specializing in corporate expense management and vendor management through its centralized purchasing management platform. The company provides software solutions designed to facilitate business dining and trip expense management, helping organizations optimize their operational efficiency. QuanCheng serves a wide market across 50 tier-one and tier-two cities in China, with an extensive presence that includes offices in major cities such as Beijing, Guangzhou, Shenzhen, and Wuhan. Early backing came from Zhenghecixi Capital, a venture capital firm established by prominent Chinese entrepreneurs.

Fishtrip is an online marketplace based in Beijing, China, catering to Chinese travelers looking for unique overseas accommodations. The platform offers a variety of lodging options, allowing users to find distinctive and unconventional places to stay during their holidays. Fishtrip operates as a subsidiary of Tujia Online Information Technology (Beijing) Co., Ltd., a company that specializes in travel-related services. By focusing on the needs of Chinese holiday-makers, Fishtrip aims to enhance the travel experience by providing access to diverse and interesting lodging alternatives across various international destinations.

Medbanks Network Technology, founded in 2014 and based in Beijing, specializes in data processing services for the healthcare sector. The company focuses on developing an oncology database that compiles clinical and professional medical service information gathered from hospitals. This resource aims to enhance the understanding and management of cancer care. In addition, Sipai Health Technology Co Ltd operates within the medical technology and health management space in China, encompassing three main segments: specialty pharmacy, physician research assistance, and health insurance services. The specialty pharmacy segment is the primary revenue driver, while the company predominantly conducts its business within the People's Republic of China.

Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacturing, and commercialization of monoclonal antibodies. The company focuses on therapeutic areas such as oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody approved for treating various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Innovent's pipeline includes several important candidates, such as IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma, and IBI-303, an adalimumab biosimilar for autoimmune diseases. The company is also developing innovative therapies for conditions like hypercholesterolemia and various cancers. With a robust portfolio of commercialized products and ongoing strategic collaborations with major pharmaceutical companies, Innovent aims to expand its impact in the global biopharmaceutical landscape. Founded in 2011, Innovent is recognized as one of China's leading biotechnology firms.

ZAKER is a mobile internet reading platform based in Guangzhou, China, that specializes in providing an aggregated news application for personalized reading experiences. The platform offers interactive and customized content by curating news from various professional media outlets, allowing users to engage in discussions based on their interests. Additionally, ZAKER supports content sharing across multiple social media platforms, enhancing user interaction. The company also provides services in content application and management, leveraging data governance capabilities to create an intelligent content ecosystem. This integrated approach aims to facilitate the intelligent upgrade of content businesses across different industries.

Eyebright Medical Technology (Beijing) Co Ltd is dedicated to the research, development, production, and sales of ophthalmic medical devices aimed at improving eye health and vision. The company offers a diverse range of products, including intraocular lenses, IOL delivery systems, surgical instruments, optometric lenses, and eye drops, all designed to address various ophthalmic conditions such as cataracts, glaucoma, and refractive errors. In addition to its product offerings, Eyebright provides related services to support the effective use of its medical devices, contributing to advancements in eye care and treatment.

Kmsocial is a provider of social media management tools aimed at enhancing promotional efficiency across various social media platforms, particularly in China. The company's primary offering is the Kongming Social Management Platform, which includes a suite of services such as Weibo operation, social media monitoring, customer relationship management (CRM), social network advertising, and data analysis. By leveraging these services, Kmsocial enables clients to effectively promote their products and manage their online presence through comprehensive social media strategies.

Zhejiang Bang Er Medical Investment Management Co., Ltd. is a prominent operator of hospitals specializing in orthopedic care and rehabilitation services, established in 2012 in Zhejiang Province, China. The company focuses on the diagnosis and treatment of various orthopedic conditions, including trauma-related injuries, hand and foot surgery, spine surgery, and joint surgery. By offering a comprehensive range of services, Bang Er aims to provide patients with the necessary care and treatment options for their orthopedic ailments, positioning itself as a key player in the healthcare sector of the Yangtze River Delta.

Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacturing, and commercialization of monoclonal antibodies. The company focuses on therapeutic areas such as oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody approved for treating various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Innovent's pipeline includes several important candidates, such as IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma, and IBI-303, an adalimumab biosimilar for autoimmune diseases. The company is also developing innovative therapies for conditions like hypercholesterolemia and various cancers. With a robust portfolio of commercialized products and ongoing strategic collaborations with major pharmaceutical companies, Innovent aims to expand its impact in the global biopharmaceutical landscape. Founded in 2011, Innovent is recognized as one of China's leading biotechnology firms.

Shanghai Lumi Information Technology Limited Company (Lumi胶原蛋白/禄美) is dedicated to research and development of beauty and health series products. Lumi is mainly engaged in the R&D, brand building, and market promotion of brand cosmetology and health products, and it is a matchless brand of collagen protein in the domestic industry. Lumi owns its market by new marketing modes, which now possesses a self-constructed call center with over a 100people and plans to extend the number to more than 200 people within the year.

Yoyi Digital is the leading platform in multi-screen programmatic buying in China. With the vision of focusing on data and technology, Yoyi Digital is leading the transformation in display ads from media buying to audience buying. At present, Yoyi has successfully completed four rounds of financing. The investors include Oak Investment Partner , Gobi Partners, Fidelity Investments, NewQuest Capital Partners, and Guangzhou Daily. Since its establishment, Yoyi has been always leading the development of programmatic buying industry. With data and technology advantages, Yoyi launched the first DSP in China which based on Real Time Biding(RTB), and also the first to bring the concept of cross-screen programmatic buying in China. In 2014, Yoyi launched Databank, China’s first real-meaning DMP, which helps advertisers on collecting, analyzing, managing, and acting on this first-party data from advertisers’ website and app as well as third-party data assembled by Yoyi and other data providers. Furthermore, Yoyi took the lead in entering the OTT indursty, launched the programmatic TV platform, established Big Data Lab by cooperating with Hisense, a Chinese famous Smart TV manufacturer，realising the data and platform integration, thus to provide more creative OTT solutions to advertisers. Yoyi is also the only DSP platform that cross multi-screens including PC, mobile,video and OTT. Based on Yoyi’s proprietary audience data and advanced advertising technology, Yoyi is able to deliver the right ads to the right audience through right screen at right time, thus greatly enhancing user experience and advertising effectiveness at the same time. Yoyi Digital provides both branding and performance solutions for over 1000 global and local brands, including Coco Cola, Budweiser, Audi, Toyota, Sumsang, Haier, Shell and Kimberly etc. Yoyi was been selected as the Red Herring 100 Global Winner, one of the technology industry's most respected awards, and also awarded the Most influential advertising company on Ad Stars Festival in Busan. Yoyi Digital was also the first ad tech company in China which been invited to give speech at Cannes Lions in France. With such strong influence，Yoyi Digital is continuously driving the revolution of digital marketing in China. Yoyi Digital is based in Beijing with branches in Shanghai and Guangzhou.

Pod Inns (布丁酒店) is a provider of contemporary and convenient accommodations in the Chinese hotel industry. It is focused on high-end customers. Pod Inns has over 300 hotels in more than 40 cities such as Beijing, Shanghai, Tianjin, Wuhan, and Xian with 8 million registered members. Since its establishment in China, Pod Inns has delivered accepted services and aims to reach higher through product innovation, professional management and service, and efficient cost control.

Hua Medicine, established in 2009, is a Shanghai-based clinical-stage drug development company. It specializes in therapies for diabetes and central nervous system (CNS) disorders in China. The company's primary focus is Dorzagliatin, an oral drug for Type 2 diabetes, which is in Phase 3 clinical trials, both as a standalone treatment and in combination with metformin. Additionally, Hua Medicine is developing Dorzagliatin in combination with other drugs and mGLUR5 for Parkinson's disease levodopa-induced dyskinesia, both in pre-clinical stages. The company's mission is to address unmet medical needs in China through innovative drug development.

BetterLife Medical is a high-tech medical device company focused on serving the Chinese market. The company specializes in developing innovative medical devices, including digital programmable hearing aids and various monitoring devices. These technologies aim to enhance the capabilities of physicians, allowing them to provide improved care to their patients. By leveraging advanced technology, BetterLife Medical is committed to addressing the healthcare needs of individuals in China.

Financial training service provider in China.

Hua Medicine, established in 2009, is a Shanghai-based clinical-stage drug development company. It specializes in therapies for diabetes and central nervous system (CNS) disorders in China. The company's primary focus is Dorzagliatin, an oral drug for Type 2 diabetes, which is in Phase 3 clinical trials, both as a standalone treatment and in combination with metformin. Additionally, Hua Medicine is developing Dorzagliatin in combination with other drugs and mGLUR5 for Parkinson's disease levodopa-induced dyskinesia, both in pre-clinical stages. The company's mission is to address unmet medical needs in China through innovative drug development.

BioRegen is a biotechnology company based in Changzhou, Jiangsu Province, China, established in April 2008. It specializes in the development of biomedical materials, regenerative medicines, and drug delivery systems with a focus on innovative solutions for clinical applications. The company is particularly known for its development of hyaluronic acid (HA) based products, which utilize extracellular matrix materials such as hyaluronan, glycosaminoglycans, and collagen. These products are designed for use in various medical fields, including ear, nose, and throat (ENT) treatments, orthopedics, and general surgeries, aiming to enhance patient healing and rejuvenation processes. BioRegen is recognized for its commitment to advancing medical technology and improving patient outcomes through its targeted therapeutic solutions.

ChinaPNR Mobile Payments Solutions Pvt. Ltd., founded in 2006 and based in Shanghai, is a financial payment company specializing in third-party payment services. It provides a comprehensive range of online, mobile, and offline payment and settlement solutions aimed at both B2B and B2C markets. The company focuses on enhancing its core competitiveness through advanced technology and operational excellence, ensuring the security of customer data while creating value for clients. Notable products include "Money Manager," which supports e-commerce within traditional distribution, and Tiantianying, a one-stop financial platform that has attracted nearly 2 million registered users. ChinaPNR has established strategic partnerships with numerous banks and fund firms, facilitating seamless investment in fund products. The company has demonstrated significant growth, with annual transaction volumes surpassing 1.8 trillion, ranking it among the leaders in the third-party payment industry.

ChinaPNR Mobile Payments Solutions Pvt. Ltd., founded in 2006 and based in Shanghai, is a financial payment company specializing in third-party payment services. It provides a comprehensive range of online, mobile, and offline payment and settlement solutions aimed at both B2B and B2C markets. The company focuses on enhancing its core competitiveness through advanced technology and operational excellence, ensuring the security of customer data while creating value for clients. Notable products include "Money Manager," which supports e-commerce within traditional distribution, and Tiantianying, a one-stop financial platform that has attracted nearly 2 million registered users. ChinaPNR has established strategic partnerships with numerous banks and fund firms, facilitating seamless investment in fund products. The company has demonstrated significant growth, with annual transaction volumes surpassing 1.8 trillion, ranking it among the leaders in the third-party payment industry.

Mineloader Software (上海皿鎏软件) is a third party game developer based in China. It has developed more than 10 AAA games. With a development team of over 200 people, clients of Mineloader includes game publishers such as CAPCOM, EA, NAMCO BANDAI, SQUARE ENIX, and TAKE TWO. Its game development team consists of experienced and top level professionals worldwide. Mineloader Software was founded in 2003 and is located in Yangpu District of Shanghai, China.

Wisers Information Limited, established in 1998 and headquartered in Wan Chai, Hong Kong, is a leading provider of Chinese media and business intelligence solutions. The company offers a diverse range of services across several business lines, including enterprise search, media and social intelligence, financial and risk intelligence, and market research. Wisers sources information from various media formats, such as online platforms, social media, print, and broadcast. Its clientele includes local blue-chip firms, Fortune 500 companies, international banks, government entities in China and Hong Kong, as well as sectors like education, retail, and transportation. Wisers also provides specialized platforms and solutions tailored for specific industries, including marketing and public relations, competitive analysis, and regulatory technology. With offices in key cities across China and Taiwan, the company empowers its clients with actionable insights, enabling informed decision-making and a deeper understanding of markets and trends.

Crystal CG Ltd. is a provider of visual creative solutions, specializing in 3D visual development and application across various sectors. Founded in 1995 and based in Beijing, the company offers services in architectural visualization, commercial property promotion, exhibition displays, and film and media production. Its capabilities extend to audio-video integrated applications and digital city platforms, catering to theme exhibitions, events, and advertising. Crystal CG also engages in research and development, design, planning, and production of film and television special effects, animation, and cartoon animation. The company operates in multiple cities, including Beijing, Shanghai, and Los Angeles, and aims to deliver integrated digital graphics solutions that support clients in achieving their goals in publicity, communication, and entertainment.

HuaXun Microelectronics Inc. is a manufacturer based in Xi'an, China, specializing in satellite positioning chipsets, OEM modules, and application systems. Founded in 2004 by a group of five PhD-holding professionals with experience in the American information technology sector, the company focuses on research and development of technologies related to GPS, Galileo, and Beidou positioning systems. Its product offerings include GPS RF chips, digital baseband chips, embedded software, handheld GPS navigators, and various GPS application systems, catering to a range of industry needs in satellite navigation and positioning solutions.

WuXi AppTec Co., Ltd. is a leading provider of research and manufacturing services aimed at supporting the discovery, development, and production of small molecule drugs, cell therapies, and gene therapies. Founded in 2000 and headquartered in Shanghai, China, the company serves clients in the pharmaceutical, biotechnology, and medical device sectors across various regions including China, the United States, Europe, and other parts of Asia. WuXi AppTec operates several segments, including chemistry, biology, and testing services, offering a comprehensive range of laboratory capabilities such as synthetic chemistry, toxicology, bioanalytical testing, and clinical research services. The company is recognized for its innovative and customer-centric approach, facilitating collaboration with over 3,900 partners worldwide to enhance the efficiency of healthcare product development. Through its extensive service offerings, WuXi AppTec aims to improve patient outcomes and advance medical science.

Novamed is a company focused on addressing significant unmet medical needs in China by developing and distributing innovative therapies. It engages in the registration, manufacturing, and sale of pharmaceutical products, primarily for non-investment purposes. In addition to its distribution efforts, Novamed provides comprehensive services that include clinical development, drug registration, importation, and commercialization for products that are in late-stage development. By facilitating these processes, Novamed supports the introduction of new therapies to the Chinese market, aiming to improve healthcare outcomes for patients.

WuXi AppTec Co., Ltd. is a leading provider of research and manufacturing services aimed at supporting the discovery, development, and production of small molecule drugs, cell therapies, and gene therapies. Founded in 2000 and headquartered in Shanghai, China, the company serves clients in the pharmaceutical, biotechnology, and medical device sectors across various regions including China, the United States, Europe, and other parts of Asia. WuXi AppTec operates several segments, including chemistry, biology, and testing services, offering a comprehensive range of laboratory capabilities such as synthetic chemistry, toxicology, bioanalytical testing, and clinical research services. The company is recognized for its innovative and customer-centric approach, facilitating collaboration with over 3,900 partners worldwide to enhance the efficiency of healthcare product development. Through its extensive service offerings, WuXi AppTec aims to improve patient outcomes and advance medical science.

WuXi AppTec Co., Ltd. is a leading provider of research and manufacturing services aimed at supporting the discovery, development, and production of small molecule drugs, cell therapies, and gene therapies. Founded in 2000 and headquartered in Shanghai, China, the company serves clients in the pharmaceutical, biotechnology, and medical device sectors across various regions including China, the United States, Europe, and other parts of Asia. WuXi AppTec operates several segments, including chemistry, biology, and testing services, offering a comprehensive range of laboratory capabilities such as synthetic chemistry, toxicology, bioanalytical testing, and clinical research services. The company is recognized for its innovative and customer-centric approach, facilitating collaboration with over 3,900 partners worldwide to enhance the efficiency of healthcare product development. Through its extensive service offerings, WuXi AppTec aims to improve patient outcomes and advance medical science.

Alibaba Group is the largest online and mobile commerce company globally, primarily known for its extensive e-commerce platforms that connect buyers and sellers. It operates notable marketplaces in China, including Taobao, which focuses on consumer-to-consumer transactions, and Tmall, which caters to business-to-consumer interactions. The company's core business lies in its China commerce retail division, which is a significant source of cash flow. In addition to retail and wholesale transactions, Alibaba also generates revenue from various sectors, including international commerce, local consumer services, cloud computing, digital media and entertainment, and logistics through its Cainiao network. Alibaba's diverse portfolio positions it as a key player across multiple industries, including retail, logistics, and technology.

Alibaba Group is the largest online and mobile commerce company globally, primarily known for its extensive e-commerce platforms that connect buyers and sellers. It operates notable marketplaces in China, including Taobao, which focuses on consumer-to-consumer transactions, and Tmall, which caters to business-to-consumer interactions. The company's core business lies in its China commerce retail division, which is a significant source of cash flow. In addition to retail and wholesale transactions, Alibaba also generates revenue from various sectors, including international commerce, local consumer services, cloud computing, digital media and entertainment, and logistics through its Cainiao network. Alibaba's diverse portfolio positions it as a key player across multiple industries, including retail, logistics, and technology.

Alibaba Group is the largest online and mobile commerce company globally, primarily known for its extensive e-commerce platforms that connect buyers and sellers. It operates notable marketplaces in China, including Taobao, which focuses on consumer-to-consumer transactions, and Tmall, which caters to business-to-consumer interactions. The company's core business lies in its China commerce retail division, which is a significant source of cash flow. In addition to retail and wholesale transactions, Alibaba also generates revenue from various sectors, including international commerce, local consumer services, cloud computing, digital media and entertainment, and logistics through its Cainiao network. Alibaba's diverse portfolio positions it as a key player across multiple industries, including retail, logistics, and technology.